News
1h
Verywell Health on MSNUnderstanding Metastatic Castration-Resistant Prostate CancerMetastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...
The company licensed technology from MIT and subsequently advanced the cellular logic gates so they could work with multiple types of engineered immune cells, including T cells and “natural killer” ...
21h
Verywell Health on MSNTreatment for Metastatic Castration-Resistant Prostate CancerMetastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
There’s more to cancer treatment than chemotherapy and radiation. Your diet, believe it or not, also plays a vital role in ...
Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 alone ...
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
2d
The Mirror US on MSNWarning as symptoms of cancer that kills 50,000 Americans a year could be 'mistaken'A doctor has issued a warning that some of the key symptoms of a potentially fatal cancer could be confused with signs of a ...
Bacteria naturally present in the human intestine (known as the gut microbiota) can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking ...
Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.
1d
News-Medical.Net on MSNSurvey reveals low awareness of innovative cancer treatment among AmericansRoswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy.
Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...
SAN DIEGO, CA, USA I April 17, 2025 I Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results